Global Adult and Pediatric Vaccines Market Size, Status and Forecast 2024-2031

Report ID: 917694 | Published Date: Jan 2025 | No. of Page: 109 | Base Year: 2024 | Rating: 3.8 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Adult and Pediatric Vaccines Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
        1.2.2 Adult Vaccines
        1.2.3 Pediatric Vaccines
    1.3 Market by Application
        1.3.1 Global Adult and Pediatric Vaccines Market Share by Application: 2016 VS 2021 VS 2027
        1.3.2 Hospitals
        1.3.3 Medical Care Centers
        1.3.4 Others
    1.4 Study Objectives
    1.5 Years Considered

2 Global Growth Trends
    2.1 Global Adult and Pediatric Vaccines Market Perspective (2016-2027)
    2.2 Adult and Pediatric Vaccines Growth Trends by Regions
        2.2.1 Adult and Pediatric Vaccines Market Size by Regions: 2016 VS 2021 VS 2027
        2.2.2 Adult and Pediatric Vaccines Historic Market Share by Regions (2016-2021)
        2.2.3 Adult and Pediatric Vaccines Forecasted Market Size by Regions (2022-2027)
    2.3 Adult and Pediatric Vaccines Industry Dynamic
        2.3.1 Adult and Pediatric Vaccines Market Trends
        2.3.2 Adult and Pediatric Vaccines Market Drivers
        2.3.3 Adult and Pediatric Vaccines Market Challenges
        2.3.4 Adult and Pediatric Vaccines Market Restraints

3 Competition Landscape by Key Players
    3.1 Global Top Adult and Pediatric Vaccines Players by Revenue
        3.1.1 Global Top Adult and Pediatric Vaccines Players by Revenue (2016-2021)
        3.1.2 Global Adult and Pediatric Vaccines Revenue Market Share by Players (2016-2021)
    3.2 Global Adult and Pediatric Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    3.3 Players Covered: Ranking by Adult and Pediatric Vaccines Revenue
    3.4 Global Adult and Pediatric Vaccines Market Concentration Ratio
        3.4.1 Global Adult and Pediatric Vaccines Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Adult and Pediatric Vaccines Revenue in 2020
    3.5 Adult and Pediatric Vaccines Key Players Head office and Area Served
    3.6 Key Players Adult and Pediatric Vaccines Product Solution and Service
    3.7 Date of Enter into Adult and Pediatric Vaccines Market
    3.8 Mergers & Acquisitions, Expansion Plans

4 Adult and Pediatric Vaccines Breakdown Data by Type
    4.1 Global Adult and Pediatric Vaccines Historic Market Size by Type (2016-2021)
    4.2 Global Adult and Pediatric Vaccines Forecasted Market Size by Type (2022-2027)

5 Adult and Pediatric Vaccines Breakdown Data by Application
    5.1 Global Adult and Pediatric Vaccines Historic Market Size by Application (2016-2021)
    5.2 Global Adult and Pediatric Vaccines Forecasted Market Size by Application (2022-2027)

6 North America
    6.1 North America Adult and Pediatric Vaccines Market Size (2016-2027)
    6.2 North America Adult and Pediatric Vaccines Market Size by Type
        6.2.1 North America Adult and Pediatric Vaccines Market Size by Type (2016-2021)
        6.2.2 North America Adult and Pediatric Vaccines Market Size by Type (2022-2027)
        6.2.3 North America Adult and Pediatric Vaccines Market Size by Type (2016-2027)
    6.3 North America Adult and Pediatric Vaccines Market Size by Application
        6.3.1 North America Adult and Pediatric Vaccines Market Size by Application (2016-2021)
        6.3.2 North America Adult and Pediatric Vaccines Market Size by Application (2022-2027)
        6.3.3 North America Adult and Pediatric Vaccines Market Size by Application (2016-2027)
    6.4 North America Adult and Pediatric Vaccines Market Size by Country
        6.4.1 North America Adult and Pediatric Vaccines Market Size by Country (2016-2021)
        6.4.2 North America Adult and Pediatric Vaccines Market Size by Country (2022-2027)
        6.4.3 United States
        6.4.4 Canada

7 Europe
    7.1 Europe Adult and Pediatric Vaccines Market Size (2016-2027)
    7.2 Europe Adult and Pediatric Vaccines Market Size by Type
        7.2.1 Europe Adult and Pediatric Vaccines Market Size by Type (2016-2021)
        7.2.2 Europe Adult and Pediatric Vaccines Market Size by Type (2022-2027)
        7.2.3 Europe Adult and Pediatric Vaccines Market Size by Type (2016-2027)
    7.3 Europe Adult and Pediatric Vaccines Market Size by Application
        7.3.1 Europe Adult and Pediatric Vaccines Market Size by Application (2016-2021)
        7.3.2 Europe Adult and Pediatric Vaccines Market Size by Application (2022-2027)
        7.3.3 Europe Adult and Pediatric Vaccines Market Size by Application (2016-2027)
    7.4 Europe Adult and Pediatric Vaccines Market Size by Country
        7.4.1 Europe Adult and Pediatric Vaccines Market Size by Country (2016-2021)
        7.4.2 Europe Adult and Pediatric Vaccines Market Size by Country (2022-2027)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic

8 Asia-Pacific
    8.1 Asia-Pacific Adult and Pediatric Vaccines Market Size (2016-2027)
    8.2 Asia-Pacific Adult and Pediatric Vaccines Market Size by Type
        8.2.1 Asia-Pacific Adult and Pediatric Vaccines Market Size by Type (2016-2021)
        8.2.2 Asia-Pacific Adult and Pediatric Vaccines Market Size by Type (2022-2027)
        8.2.3 Asia-Pacific Adult and Pediatric Vaccines Market Size by Type (2016-2027)
    8.3 Asia-Pacific Adult and Pediatric Vaccines Market Size by Application
        8.3.1 Asia-Pacific Adult and Pediatric Vaccines Market Size by Application (2016-2021)
        8.3.2 Asia-Pacific Adult and Pediatric Vaccines Market Size by Application (2022-2027)
        8.3.3 Asia-Pacific Adult and Pediatric Vaccines Market Size by Application (2016-2027)
    8.4 Asia-Pacific Adult and Pediatric Vaccines Market Size by Region
        8.4.1 Asia-Pacific Adult and Pediatric Vaccines Market Size by Region (2016-2021)
        8.4.2 Asia-Pacific Adult and Pediatric Vaccines Market Size by Region (2022-2027)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia

9 Latin America
    9.1 Latin America Adult and Pediatric Vaccines Market Size (2016-2027)
    9.2 Latin America Adult and Pediatric Vaccines Market Size by Type
        9.2.1 Latin America Adult and Pediatric Vaccines Market Size by Type (2016-2021)
        9.2.2 Latin America Adult and Pediatric Vaccines Market Size by Type (2022-2027)
        9.2.3 Latin America Adult and Pediatric Vaccines Market Size by Type (2016-2027)
    9.3 Latin America Adult and Pediatric Vaccines Market Size by Application
        9.3.1 Latin America Adult and Pediatric Vaccines Market Size by Application (2016-2021)
        9.3.2 Latin America Adult and Pediatric Vaccines Market Size by Application (2022-2027)
        9.3.3 Latin America Adult and Pediatric Vaccines Market Size by Application (2016-2027)
    9.4 Latin America Adult and Pediatric Vaccines Market Size by Country
        9.4.1 Latin America Adult and Pediatric Vaccines Market Size by Country (2016-2021)
        9.4.2 Latin America Adult and Pediatric Vaccines Market Size by Country (2022-2027)
        9.4.3 Mexico
        9.4.4 Brazil

10 Middle East & Africa
    10.1 Middle East & Africa Adult and Pediatric Vaccines Market Size (2016-2027)
    10.2 Middle East & Africa Adult and Pediatric Vaccines Market Size by Type
        10.2.1 Middle East & Africa Adult and Pediatric Vaccines Market Size by Type (2016-2021)
        10.2.2 Middle East & Africa Adult and Pediatric Vaccines Market Size by Type (2022-2027)
        10.2.3 Middle East & Africa Adult and Pediatric Vaccines Market Size by Type (2016-2027)
    10.3 Middle East & Africa Adult and Pediatric Vaccines Market Size by Application
        10.3.1 Middle East & Africa Adult and Pediatric Vaccines Market Size by Application (2016-2021)
        10.3.2 Middle East & Africa Adult and Pediatric Vaccines Market Size by Application (2022-2027)
        10.3.3 Middle East & Africa Adult and Pediatric Vaccines Market Size by Application (2016-2027)
    10.4 Middle East & Africa Adult and Pediatric Vaccines Market Size by Country
        10.4.1 Middle East & Africa Adult and Pediatric Vaccines Market Size by Country (2016-2021)
        10.4.2 Middle East & Africa Adult and Pediatric Vaccines Market Size by Country (2022-2027)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE

11 Key Players Profiles
    11.1 GlaxoSmithKline
        11.1.1 GlaxoSmithKline Company Details
        11.1.2 GlaxoSmithKline Business Overview
        11.1.3 GlaxoSmithKline Adult and Pediatric Vaccines Introduction
        11.1.4 GlaxoSmithKline Revenue in Adult and Pediatric Vaccines Business (2016-2021)
        11.1.5 GlaxoSmithKline Recent Development
    11.2 Sanofi
        11.2.1 Sanofi Company Details
        11.2.2 Sanofi Business Overview
        11.2.3 Sanofi Adult and Pediatric Vaccines Introduction
        11.2.4 Sanofi Revenue in Adult and Pediatric Vaccines Business (2016-2021)
        11.2.5 Sanofi Recent Development
    11.3 Merck
        11.3.1 Merck Company Details
        11.3.2 Merck Business Overview
        11.3.3 Merck Adult and Pediatric Vaccines Introduction
        11.3.4 Merck Revenue in Adult and Pediatric Vaccines Business (2016-2021)
        11.3.5 Merck Recent Development
    11.4 Novartis
        11.4.1 Novartis Company Details
        11.4.2 Novartis Business Overview
        11.4.3 Novartis Adult and Pediatric Vaccines Introduction
        11.4.4 Novartis Revenue in Adult and Pediatric Vaccines Business (2016-2021)
        11.4.5 Novartis Recent Development
    11.5 Pfizer
        11.5.1 Pfizer Company Details
        11.5.2 Pfizer Business Overview
        11.5.3 Pfizer Adult and Pediatric Vaccines Introduction
        11.5.4 Pfizer Revenue in Adult and Pediatric Vaccines Business (2016-2021)
        11.5.5 Pfizer Recent Development
    11.6 AstraZeneca
        11.6.1 AstraZeneca Company Details
        11.6.2 AstraZeneca Business Overview
        11.6.3 AstraZeneca Adult and Pediatric Vaccines Introduction
        11.6.4 AstraZeneca Revenue in Adult and Pediatric Vaccines Business (2016-2021)
        11.6.5 AstraZeneca Recent Development
    11.7 Johnson and Johnson
        11.7.1 Johnson and Johnson Company Details
        11.7.2 Johnson and Johnson Business Overview
        11.7.3 Johnson and Johnson Adult and Pediatric Vaccines Introduction
        11.7.4 Johnson and Johnson Revenue in Adult and Pediatric Vaccines Business (2016-2021)
        11.7.5 Johnson and Johnson Recent Development
    11.8 Takeda Pharmaceutical
        11.8.1 Takeda Pharmaceutical Company Details
        11.8.2 Takeda Pharmaceutical Business Overview
        11.8.3 Takeda Pharmaceutical Adult and Pediatric Vaccines Introduction
        11.8.4 Takeda Pharmaceutical Revenue in Adult and Pediatric Vaccines Business (2016-2021)
        11.8.5 Takeda Pharmaceutical Recent Development
    11.9 Bavarian Nordic
        11.9.1 Bavarian Nordic Company Details
        11.9.2 Bavarian Nordic Business Overview
        11.9.3 Bavarian Nordic Adult and Pediatric Vaccines Introduction
        11.9.4 Bavarian Nordic Revenue in Adult and Pediatric Vaccines Business (2016-2021)
        11.9.5 Bavarian Nordic Recent Development
    11.10 LG Life Sciences
        11.10.1 LG Life Sciences Company Details
        11.10.2 LG Life Sciences Business Overview
        11.10.3 LG Life Sciences Adult and Pediatric Vaccines Introduction
        11.10.4 LG Life Sciences Revenue in Adult and Pediatric Vaccines Business (2016-2021)
        11.10.5 LG Life Sciences Recent Development
    11.11 Sinovac Biotech
        11.11.1 Sinovac Biotech Company Details
        11.11.2 Sinovac Biotech Business Overview
        11.11.3 Sinovac Biotech Adult and Pediatric Vaccines Introduction
        11.11.4 Sinovac Biotech Revenue in Adult and Pediatric Vaccines Business (2016-2021)
        11.11.5 Sinovac Biotech Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details
List of Tables
    Table 1. Global Adult and Pediatric Vaccines Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
    Table 2. Key Players of Adult Vaccines
    Table 3. Key Players of Pediatric Vaccines
    Table 4. Global Adult and Pediatric Vaccines Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
    Table 5. Global Adult and Pediatric Vaccines Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
    Table 6. Global Adult and Pediatric Vaccines Market Size by Regions (2016-2021) & (US$ Million)
    Table 7. Global Adult and Pediatric Vaccines Market Share by Regions (2016-2021)
    Table 8. Global Adult and Pediatric Vaccines Forecasted Market Size by Regions (2022-2027) & (US$ Million)
    Table 9. Global Adult and Pediatric Vaccines Market Share by Regions (2022-2027)
    Table 10. Adult and Pediatric Vaccines Market Trends
    Table 11. Adult and Pediatric Vaccines Market Drivers
    Table 12. Adult and Pediatric Vaccines Market Challenges
    Table 13. Adult and Pediatric Vaccines Market Restraints
    Table 14. Global Adult and Pediatric Vaccines Revenue by Players (2016-2021) & (US$ Million)
    Table 15. Global Adult and Pediatric Vaccines Market Share by Players (2016-2021)
    Table 16. Global Top Adult and Pediatric Vaccines Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Adult and Pediatric Vaccines as of 2020)
    Table 17. Ranking of Global Top Adult and Pediatric Vaccines Companies by Revenue (US$ Million) in 2020
    Table 18. Global 5 Largest Players Market Share by Adult and Pediatric Vaccines Revenue (CR5 and HHI) & (2016-2021)
    Table 19. Key Players Headquarters and Area Served
    Table 20. Key Players Adult and Pediatric Vaccines Product Solution and Service
    Table 21. Date of Enter into Adult and Pediatric Vaccines Market
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global Adult and Pediatric Vaccines Market Size by Type (2016-2021) (US$ Million)
    Table 24. Global Adult and Pediatric Vaccines Revenue Market Share by Type (2016-2021)
    Table 25. Global Adult and Pediatric Vaccines Forecasted Market Size by Type (2022-2027) (US$ Million)
    Table 26. Global Adult and Pediatric Vaccines Revenue Market Share by Type (2022-2027) & (US$ Million)
    Table 27. Global Adult and Pediatric Vaccines Market Size Share by Application (2016-2021) & (US$ Million)
    Table 28. Global Adult and Pediatric Vaccines Revenue Market Share by Application (2016-2021)
    Table 29. Global Adult and Pediatric Vaccines Forecasted Market Size by Application (2022-2027) (US$ Million)
    Table 30. Global Adult and Pediatric Vaccines Revenue Market Share by Application (2022-2027) & (US$ Million)
    Table 31. North America Adult and Pediatric Vaccines Market Size by Type (2016-2021) (US$ Million)
    Table 32. North America Adult and Pediatric Vaccines Market Size by Type (2022-2027) & (US$ Million)
    Table 33. North America Adult and Pediatric Vaccines Market Size by Application (2016-2021) (US$ Million)
    Table 34. North America Adult and Pediatric Vaccines Market Size by Application (2022-2027) & (US$ Million)
    Table 35. North America Adult and Pediatric Vaccines Market Size by Country (2016-2021) & (US$ Million) 
    Table 36. North America Adult and Pediatric Vaccines Market Size by Country (2022-2027) & (US$ Million) 
    Table 37. Europe Adult and Pediatric Vaccines Market Size by Type (2016-2021) (US$ Million)
    Table 38. Europe Adult and Pediatric Vaccines Market Size by Type (2022-2027) & (US$ Million)
    Table 39. Europe Adult and Pediatric Vaccines Market Size by Application (2016-2021) (US$ Million)
    Table 40. Europe Adult and Pediatric Vaccines Market Size by Application (2022-2027) & (US$ Million)
    Table 41. Europe Adult and Pediatric Vaccines Market Size by Country (2016-2021) & (US$ Million) 
    Table 42. Europe Adult and Pediatric Vaccines Market Size by Country (2022-2027) & (US$ Million) 
    Table 43. Asia-Pacific Adult and Pediatric Vaccines Market Size by Type (2016-2021) (US$ Million)
    Table 44. Asia-Pacific Adult and Pediatric Vaccines Market Size by Type (2022-2027) & (US$ Million)
    Table 45. Asia-Pacific Adult and Pediatric Vaccines Market Size by Application (2016-2021) (US$ Million)
    Table 46. Asia-Pacific Adult and Pediatric Vaccines Market Size by Application (2022-2027) & (US$ Million)
    Table 47. Asia-Pacific Adult and Pediatric Vaccines Market Size by Region (2016-2021) & (US$ Million) 
    Table 48. Asia-Pacific Adult and Pediatric Vaccines Market Size by Region (2022-2027) & (US$ Million) 
    Table 49. Latin America Adult and Pediatric Vaccines Market Size by Type (2016-2021) (US$ Million)
    Table 50. Latin America Adult and Pediatric Vaccines Market Size by Type (2022-2027) & (US$ Million)
    Table 51. Latin America Adult and Pediatric Vaccines Market Size by Application (2016-2021) (US$ Million)
    Table 52. Latin America Adult and Pediatric Vaccines Market Size by Application (2022-2027) & (US$ Million)
    Table 53. Latin America Adult and Pediatric Vaccines Market Size by Country (2016-2021) & (US$ Million) 
    Table 54. Latin America Adult and Pediatric Vaccines Market Size by Country (2022-2027) & (US$ Million) 
    Table 55. Middle East & Africa Adult and Pediatric Vaccines Market Size by Type (2016-2021) (US$ Million)
    Table 56. Middle East & Africa Adult and Pediatric Vaccines Market Size by Type (2022-2027) & (US$ Million)
    Table 57. Middle East & Africa Adult and Pediatric Vaccines Market Size by Application (2016-2021) (US$ Million)
    Table 58. Middle East & Africa Adult and Pediatric Vaccines Market Size by Application (2022-2027) & (US$ Million)
    Table 59. Middle East & Africa Adult and Pediatric Vaccines Market Size by Country (2016-2021) & (US$ Million) 
    Table 60. Middle East & Africa Adult and Pediatric Vaccines Market Size by Country (2022-2027) & (US$ Million) 
    Table 61. GlaxoSmithKline Company Details
    Table 62. GlaxoSmithKline Business Overview
    Table 63. GlaxoSmithKline Adult and Pediatric Vaccines Product
    Table 64. GlaxoSmithKline Revenue in Adult and Pediatric Vaccines Business (2016-2021) & (US$ Million)
    Table 65. GlaxoSmithKline Recent Development
    Table 66. Sanofi Company Details
    Table 67. Sanofi Business Overview
    Table 68. Sanofi Adult and Pediatric Vaccines Product
    Table 69. Sanofi Revenue in Adult and Pediatric Vaccines Business (2016-2021) & (US$ Million)
    Table 70. Sanofi Recent Development
    Table 71. Merck Company Details
    Table 72. Merck Business Overview
    Table 73. Merck Adult and Pediatric Vaccines Product
    Table 74. Merck Revenue in Adult and Pediatric Vaccines Business (2016-2021) & (US$ Million)
    Table 75. Merck Recent Development
    Table 76. Novartis Company Details
    Table 77. Novartis Business Overview
    Table 78. Novartis Adult and Pediatric Vaccines Product
    Table 79. Novartis Revenue in Adult and Pediatric Vaccines Business (2016-2021) & (US$ Million)
    Table 80. Novartis Recent Development
    Table 81. Pfizer Company Details
    Table 82. Pfizer Business Overview
    Table 83. Pfizer Adult and Pediatric Vaccines Product
    Table 84. Pfizer Revenue in Adult and Pediatric Vaccines Business (2016-2021) & (US$ Million)
    Table 85. Pfizer Recent Development
    Table 86. AstraZeneca Company Details
    Table 87. AstraZeneca Business Overview
    Table 88. AstraZeneca Adult and Pediatric Vaccines Product
    Table 89. AstraZeneca Revenue in Adult and Pediatric Vaccines Business (2016-2021) & (US$ Million)
    Table 90. AstraZeneca Recent Development
    Table 91. Johnson and Johnson Company Details
    Table 92. Johnson and Johnson Business Overview
    Table 93. Johnson and Johnson Adult and Pediatric Vaccines Product
    Table 94. Johnson and Johnson Revenue in Adult and Pediatric Vaccines Business (2016-2021) & (US$ Million)
    Table 95. Johnson and Johnson Recent Development
    Table 96. Takeda Pharmaceutical Company Details
    Table 97. Takeda Pharmaceutical Business Overview
    Table 98. Takeda Pharmaceutical Revenue in Adult and Pediatric Vaccines Business (2016-2021) & (US$ Million)
    Table 99. Takeda Pharmaceutical Recent Development
    Table 100. Bavarian Nordic Company Details
    Table 101. Bavarian Nordic Business Overview
    Table 102. Bavarian Nordic Adult and Pediatric Vaccines Product
    Table 103. Bavarian Nordic Revenue in Adult and Pediatric Vaccines Business (2016-2021) & (US$ Million)
    Table 104. Bavarian Nordic Recent Development
    Table 105. LG Life Sciences Company Details
    Table 106. LG Life Sciences Business Overview
    Table 107. LG Life Sciences Adult and Pediatric Vaccines Product
    Table 108. LG Life Sciences Revenue in Adult and Pediatric Vaccines Business (2016-2021) & (US$ Million)
    Table 109. LG Life Sciences Recent Development
    Table 110. Sinovac Biotech Company Details
    Table 111. Sinovac Biotech Business Overview
    Table 112. Sinovac Biotech Adult and Pediatric Vaccines Product
    Table 113. Sinovac Biotech Revenue in Adult and Pediatric Vaccines Business (2016-2021) & (US$ Million)
    Table 114. Sinovac Biotech Recent Development
    Table 115. Research Programs/Design for This Report
    Table 116. Key Data Information from Secondary Sources
    Table 117. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Adult and Pediatric Vaccines Market Share by Type: 2020 VS 2027
    Figure 2. Adult Vaccines Features
    Figure 3. Pediatric Vaccines Features
    Figure 4. Global Adult and Pediatric Vaccines Market Share by Application: 2020 VS 2027
    Figure 5. Hospitals Case Studies
    Figure 6. Medical Care Centers Case Studies
    Figure 7. Others Case Studies
    Figure 8. Adult and Pediatric Vaccines Report Years Considered
    Figure 9. Global Adult and Pediatric Vaccines Market Size (US$ Million), Year-over-Year: 2016-2027
    Figure 10. Global Adult and Pediatric Vaccines Market Size (US$ Million), 2016 VS 2021 VS 2027
    Figure 11. Global Adult and Pediatric Vaccines Market Share by Regions: 2020 VS 2027
    Figure 12. Global Adult and Pediatric Vaccines Market Share by Regions (2022-2027)
    Figure 13. Global Adult and Pediatric Vaccines Market Share by Players in 2020
    Figure 14. Global Top Adult and Pediatric Vaccines Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Adult and Pediatric Vaccines as of 2020
    Figure 15. The Top 10 and 5 Players Market Share by Adult and Pediatric Vaccines Revenue in 2020
    Figure 16. Global Adult and Pediatric Vaccines Revenue Market Share by Type (2016-2021)
    Figure 17. Global Adult and Pediatric Vaccines Revenue Market Share by Type (2022-2027)
    Figure 18. North America Adult and Pediatric Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 19. North America Adult and Pediatric Vaccines Market Share by Type (2016-2027)
    Figure 20. North America Adult and Pediatric Vaccines Market Share by Application (2016-2027)
    Figure 21. North America Adult and Pediatric Vaccines Market Share by Country (2016-2027)
    Figure 22. United States Adult and Pediatric Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 23. Canada Adult and Pediatric Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 24. Europe Adult and Pediatric Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 25. Europe Adult and Pediatric Vaccines Market Share by Type (2016-2027)
    Figure 26. Europe Adult and Pediatric Vaccines Market Share by Application (2016-2027)
    Figure 27. Europe Adult and Pediatric Vaccines Market Share by Country (2016-2027)
    Figure 28. Germany Adult and Pediatric Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 29. France Adult and Pediatric Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 30. U.K. Adult and Pediatric Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 31. Italy Adult and Pediatric Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 32. Russia Adult and Pediatric Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 33. Nordic Adult and Pediatric Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 34. Asia-Pacific Adult and Pediatric Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 35. Asia-Pacific Adult and Pediatric Vaccines Market Share by Type (2016-2027)
    Figure 36. Asia-Pacific Adult and Pediatric Vaccines Market Share by Application (2016-2027)
    Figure 37. Asia-Pacific Adult and Pediatric Vaccines Market Share by Region (2016-2027)
    Figure 38. China Adult and Pediatric Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 39. Japan Adult and Pediatric Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 40. South Korea Adult and Pediatric Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 41. Southeast Asia Adult and Pediatric Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 42. India Adult and Pediatric Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 43. Australia Adult and Pediatric Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 44. Latin America Adult and Pediatric Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 45. Latin America Adult and Pediatric Vaccines Market Share by Type (2016-2027)
    Figure 46. Latin America Adult and Pediatric Vaccines Market Share by Application (2016-2027)
    Figure 47. Latin America Adult and Pediatric Vaccines Market Share by Country (2016-2027)
    Figure 48. Mexico Adult and Pediatric Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 49. Brazil Adult and Pediatric Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 50. Middle East & Africa Adult and Pediatric Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 51. Middle East & Africa Adult and Pediatric Vaccines Market Share by Type (2016-2027)
    Figure 52. Middle East & Africa Adult and Pediatric Vaccines Market Share by Application (2016-2027)
    Figure 53. Middle East & Africa Adult and Pediatric Vaccines Market Share by Country (2016-2027)
    Figure 54. Turkey Adult and Pediatric Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 55. Saudi Arabia Adult and Pediatric Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 56. UAE Adult and Pediatric Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 57. GlaxoSmithKline Revenue Growth Rate in Adult and Pediatric Vaccines Business (2016-2021)
    Figure 58. Sanofi Revenue Growth Rate in Adult and Pediatric Vaccines Business (2016-2021)
    Figure 59. Merck Revenue Growth Rate in Adult and Pediatric Vaccines Business (2016-2021)
    Figure 60. Novartis Revenue Growth Rate in Adult and Pediatric Vaccines Business (2016-2021)
    Figure 61. Pfizer Revenue Growth Rate in Adult and Pediatric Vaccines Business (2016-2021)
    Figure 62. AstraZeneca Revenue Growth Rate in Adult and Pediatric Vaccines Business (2016-2021)
    Figure 63. Johnson and Johnson Revenue Growth Rate in Adult and Pediatric Vaccines Business (2016-2021)
    Figure 64. Takeda Pharmaceutical Revenue Growth Rate in Adult and Pediatric Vaccines Business (2016-2021)
    Figure 65. Bavarian Nordic Revenue Growth Rate in Adult and Pediatric Vaccines Business (2016-2021)
    Figure 66. LG Life Sciences Revenue Growth Rate in Adult and Pediatric Vaccines Business (2016-2021)
    Figure 67. Sinovac Biotech Revenue Growth Rate in Adult and Pediatric Vaccines Business (2016-2021)
    Figure 68. Bottom-up and Top-down Approaches for This Report
    Figure 69. Data Triangulation
    Figure 70. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
GlaxoSmithKline
Sanofi
Merck
Novartis
Pfizer
AstraZeneca
Johnson and Johnson
Takeda Pharmaceutical
Bavarian Nordic
LG Life Sciences
Sinovac Biotech
Frequently Asked Questions
Adult and Pediatric Vaccines report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Adult and Pediatric Vaccines report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Adult and Pediatric Vaccines report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

DNA Vaccination

DNA vaccination is a technique for protecting against disease by injection with genetically engin ... Read More